| Dr Coy Bergeron, PHARM D | |
|
4710 Johnston St, Lafayette, LA 70503-4541 | |
| (337) 988-7284 | |
| Not Available |
| Full Name | Dr Coy Bergeron |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 4710 Johnston St, Lafayette, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164732400 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 19214 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Coy Bergeron, PHARM D 231 Iseringhausen Rd, Church Point, LA 70525-7511 Ph: (337) 278-3706 | Dr Coy Bergeron, PHARM D 4710 Johnston St, Lafayette, LA 70503-4541 Ph: (337) 988-7284 |
News Archive
Fibroid tumors — the sometimes painful uterine growths affecting many American women — lack a key protein that plays a role in holding tissues together, according to a study by researchers from the Uniformed Services University of the Health Sciences (USUHS) and the National Institute of Child Health and Human Development of the National Institutes of Health.
A new study, released on the bioRxiv* preprint server, describes the mechanism of inflammation in severe COVID-19, besides revealing a potential new therapeutic target to modulate the severity of COVID-19.
Dr. Tom Hudson, President and Scientific Director of the Ontario Institute for Cancer Research today welcomed the Government of Canada's announcement of support for cancer control with a renewal of the mandate of the Canadian Partnership Against Cancer for five years and $250 million in funding.
Chemokine Therapeutics has announced that it has been granted U.S. Patent No. 6,875,738 relating to the use of its anti-cancer compound, CTCE-9908, in the treatment of cancer and inhibition of angiogenesis. CTCE-9908 is designed to block CXCR4, a receptor found on the surface of cancer cells.
Young women who start using hormonal contraceptives for birth control often stop using condoms, but a new study in the Journal of Adolescent Health finds that if they later discontinue using hormonal contraceptives, they tend not to resume using condoms. This leaves them open to both unintended pregnancy and sexually transmitted infections (STIs).
› Verified 4 days ago
Philip Asare, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2517 Kaliste Saloon Rd, Lafayette, LA 70508 Phone: 337-216-9187 | |
Tammie Koelz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2701 Johnston St, Suite 200, Lafayette, LA 70503 Phone: 337-234-0197 Fax: 337-234-6939 | |
Dr. Jami Jenkins, PHARMD,RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3142 Ambassador Caffery Pkwy, Lafayette, LA 70506 Phone: 337-989-4095 | |
Jude K Fuselier, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4710 Johnston St, Lafayette, LA 70503 Phone: 337-988-7284 | |
Tuan Tran, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2700 Johnston St, Lafayette, LA 70503 Phone: 337-232-9317 | |
Ellis Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4600 Ambassador Caffery Pkwy, Lafayette, LA 70508 Phone: 337-470-5500 | |
Mr. Christopher Jude Morrow, R.PH., BSPHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3747 Moss St, Lafayette, LA 70507 Phone: 337-291-1808 |